SOAP Note: 78-Year-Old Male Medicare Wellness Exam with Chronic AAA
SUBJECTIVE
Chief Complaint: Follow-up Medicare Annual Wellness Visit
History of Present Illness:
- 78-year-old male presents for Medicare Annual Wellness Visit
- Reports abdominal bloating (onset, duration, severity, associated symptoms not specified)
- Currently vaping (frequency and duration not specified)
- Known chronic non-ruptured abdominal aortic aneurysm, monitored every 3 years with abdominal ultrasound and MRI
- Most recent AAA imaging report shows stable aneurysm
- Due for colonoscopy
Past Medical History:
- Chronic non-ruptured abdominal aortic aneurysm
- Hypertension
- Hyperlipidemia
- Benign prostatic hyperplasia (BPH)
Social History:
- Current vaping use (significant risk factor for AAA progression and rupture)
- Smoking history: unclear if former smoker or only current vaper
Medications: (Not specified - should include antihypertensives, statins)
Allergies: (Not specified)
OBJECTIVE
Vital Signs: (Not provided - should include BP, HR, weight, BMI)
Physical Examination:
- General: (Not specified)
- Cardiovascular: (Not specified - should include peripheral pulses, abdominal aortic pulsation assessment)
- Abdomen: (Not specified - should assess for tenderness, distension related to bloating complaint)
- Extremities: (Not specified - should assess for peripheral vascular disease)
Cognitive Assessment:
- SLUMS (Saint Louis University Mental Status) examination performed in office (score not provided)
Recent Imaging:
- AAA surveillance imaging (ultrasound and MRI) shows stable aneurysm (specific diameter not provided)
ASSESSMENT
Primary Diagnoses:
Chronic non-ruptured abdominal aortic aneurysm, stable (ICD-10: I71.4)
- Critical management issue: This patient requires more frequent AAA surveillance than every 3 years. Current monitoring interval is inappropriate and potentially dangerous. 1, 2
- As a 78-year-old male with vaping history (nicotine use), he meets USPSTF Grade B recommendation criteria for AAA screening and requires diameter-based surveillance. 1, 3
- Surveillance intervals should be: 3.0-3.9 cm every 3 years; 4.0-4.9 cm annually; 5.0-5.4 cm every 6 months 4
- Vaping represents ongoing nicotine exposure and significantly increases AAA rupture risk - requires aggressive cessation counseling 5
Abdominal bloating, unspecified (ICD-10: R14.0)
- Requires gastroenterology evaluation to rule out malignancy, inflammatory bowel disease, or other pathology
- Patient overdue for colonoscopy screening
Nicotine dependence, vaping (ICD-10: F17.290)
Essential hypertension (ICD-10: I10)
Hyperlipidemia (ICD-10: E78.5)
Benign prostatic hyperplasia (ICD-10: N40.0)
Encounter for screening for malignant neoplasm of colon (ICD-10: Z12.11)
- Overdue for colonoscopy
PLAN
1. Abdominal Aortic Aneurysm Management
Immediate Actions:
- Obtain exact AAA diameter from most recent imaging report to determine appropriate surveillance interval
- Correct surveillance protocol:
- Discontinue MRI for routine surveillance - ultrasound is the recommended modality for AAA monitoring per USPSTF and ACR guidelines 1, 4
- Reserve CT angiography for pre-operative planning only if surgical repair becomes indicated 4, 6
Risk Factor Modification:
- Smoking/vaping cessation is mandatory - Grade A recommendation 2
- Prescribe combination nicotine replacement therapy + varenicline or bupropion
- Refer to tobacco cessation program
- Document that continued vaping significantly increases rupture risk and mortality
- Blood pressure control: Target SBP 120-129 mmHg 2
- Ensure ACE inhibitor or ARB in regimen
- Lipid management: Target LDL-C <55 mg/dL with >50% reduction 2
- High-intensity statin required
- Add ezetimibe if not at goal
- Consider PCSK9 inhibitor if maximally tolerated statin + ezetimibe insufficient
2. Abdominal Bloating
- Refer to Gastroenterology for evaluation of abdominal bloating and overdue colonoscopy
- Consider basic workup: CBC, CMP, celiac panel, stool studies if indicated
- Colonoscopy scheduling per GI recommendations
3. Hypertension
- Review current antihypertensive regimen (not provided)
- Ensure includes ACE inhibitor or ARB 2
- Titrate to achieve SBP 120-129 mmHg
- Home blood pressure monitoring
4. Hyperlipidemia
- Check fasting lipid panel
- Ensure on high-intensity statin (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) 2
- Add ezetimibe 10 mg daily if LDL-C not <55 mg/dL
- Consider PCSK9 inhibitor if target not achieved on statin + ezetimibe
5. Benign Prostatic Hyperplasia
- Continue current management
- Assess symptom control
6. Medicare Annual Wellness Visit Components
- SLUMS cognitive assessment completed (document score)
- Update advance directives
- Review preventive services
- Medication reconciliation
- Fall risk assessment
- Depression screening (PHQ-2/PHQ-9)
- Functional status assessment
7. Patient Education
- Extensive counseling on AAA rupture risk with continued vaping - emphasize mortality risk
- Mediterranean diet for cardiovascular disease prevention 2
- Regular low-to-moderate intensity aerobic activity as tolerated 2
- Importance of blood pressure and lipid control
- Warning signs of AAA rupture: sudden severe abdominal/back pain, syncope - call 911 immediately
ORDERS/REFERRALS
Laboratory:
- Fasting lipid panel
- Basic metabolic panel
- HbA1c (if not recently checked)
- CBC
Imaging:
- Review exact diameter from most recent AAA imaging
- Schedule next AAA ultrasound based on diameter (see surveillance intervals above)
Referrals:
- Gastroenterology - for abdominal bloating evaluation and colonoscopy
- Tobacco cessation program - urgent
- Consider vascular surgery consultation if AAA ≥5.0 cm for discussion of repair timing
Prescriptions:
- Nicotine replacement therapy (patch + gum/lozenge)
- Varenicline 0.5 mg daily x3 days, then 0.5 mg BID x4 days, then 1 mg BID x11 weeks (or bupropion alternative)
- Optimize antihypertensive regimen (specific medications depend on current regimen)
- Optimize statin ± ezetimibe based on lipid panel results
CPT CODES
- G0438 - Annual wellness visit; includes a personalized prevention plan of service (PPPS), initial visit (if first AWV)
- OR G0439 - Annual wellness visit; includes a personalized prevention plan of service (PPPS), subsequent visit (if not first AWV)
- 96127 - Brief emotional/behavioral assessment (depression screening)
- 99497 - Advance care planning (if >30 minutes spent on this)
ICD-10 CODES
Primary:
- I71.4 - Abdominal aortic aneurysm, without rupture
Secondary:
- R14.0 - Abdominal distension (bloating)
- F17.290 - Nicotine dependence, unspecified, uncomplicated (vaping)
- I10 - Essential (primary) hypertension
- E78.5 - Hyperlipidemia, unspecified
- N40.0 - Benign prostatic hyperplasia without lower urinary tract symptoms
- Z12.11 - Encounter for screening for malignant neoplasm of colon
- Z00.00 - Encounter for general adult medical examination without abnormal findings (or Z00.01 if abnormal findings)
- Z13.89 - Encounter for screening for other disorder (for AAA surveillance)
FOLLOW-UP
- Return in 2-4 weeks to review laboratory results and assess tobacco cessation progress
- GI appointment as scheduled
- AAA ultrasound per diameter-based surveillance protocol
- Blood pressure recheck in 2-4 weeks if medication adjustments made
Critical safety note: The current 3-year surveillance interval for this patient's AAA is potentially dangerous and must be corrected immediately based on actual aneurysm diameter. Continued vaping with known AAA represents a life-threatening combination requiring urgent intervention. 1, 2, 5